Concepedia

Florence Zink

FZ

5

Publications

174

Citations

5

H-Index

2005

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Florence Zink is an author at Novartis (Switzerland) specializing in natural sciences, molecular biology, and cell signaling.

Top concepts

Publications per year

2005–2025

5

Publications

5

JDQ443, a Structurally Novel, Pyrazole-Based, Covalent Inhibitor of KRAS<sup>G12C</sup> for the Treatment of Solid Tumors

Edwige Lorthiois, Marc Gerspacher, Kim S. Beyer et al. · Journal of Medicinal Chemistry · 2022 · 84 citations · Full text

Crystal Structure of Human BACE2 in Complex with a Hydroxyethylamine Transition-state Inhibitor

Nils Ostermann, Jörg Eder, Ulf Eidhoff et al. · Journal of Molecular Biology · 2005 · 51 citations

, , +6

Therapeutic potential of allosteric HECT E3 ligase inhibition

Alexander Rothman, Amir Florentin, Florence Zink et al. · Cell · 2025 · 16 citations · Full text

BET bromodomain inhibitors regulate keratinocyte plasticity

Gabi Schutzius, Christian Kolter, Sebastian Bergling et al. · Nature Chemical Biology · 2021 · 13 citations

, , +3

Discovery of the TLR7/8 Antagonist MHV370 for Treatment of Systemic Autoimmune Diseases

Phil B. Alper, Claudia Betschart, Cédric André et al. · ACS Medicinal Chemistry Letters · 2023 · 10 citations · Full text

Rows per page

1–5 of 5